Cost-effectiveness of monitoring endoxifen levels in breast cancer patients adjuvantly treated with tamoxifen

被引：0
|
作者：
M. van Nuland
R. A. Vreman
R. M. T. ten Ham
A. H. M. de Vries Schultink
H. Rosing
J. H. M. Schellens
J. H. Beijnen
A. M. Hövels
机构：
[1] The Netherlands Cancer Institute and MC Slotervaart,Department of Pharmacy and Pharmacology
[2] The Netherlands Cancer Institute,Division of Pharmacology
[3] Utrecht University,Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences
[4] The Netherlands Cancer Institute,Division of Clinical Pharmacology, Department of Medical Oncology
来源：
Breast Cancer Research and Treatment | 2018年 / 172卷
关键词：
Therapeutic drug monitoring; Cost-effectiveness; Tamoxifen; Endoxifen; Breast cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：143 / 150
页数：7
相关论文
共 50 条
  • [1] Cost-effectiveness of monitoring endoxifen levels in breast cancer patients adjuvantly treated with tamoxifen
    van Nuland, M.
    Vreman, R. A.
    ten Ham, R. M. T.
    Schultink, A. H. M. de Vries
    Rosing, H.
    Schellens, J. H. M.
    Beijnen, J. H.
    Hovels, A. M.
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 172 (01) : 143 - 150
  • [2] Cost-Effectiveness of Chemoprevention of Breast Cancer Using Tamoxifen in a Postmenopausal US Population
    Noah-Vanhoucke, Joyce
    Green, Linda E.
    Dinh, Tuan A.
    Alperin, Peter
    Smith, Robert A.
    CANCER, 2011, 117 (15) : 3322 - 3331
  • [3] Serum concentrations of active tamoxifen metabolites predict long-term survival in adjuvantly treated breast cancer patients
    Thomas Helland
    Nina Henne
    Ersilia Bifulco
    Bjørn Naume
    Elin Borgen
    Vessela N. Kristensen
    Jan T. Kvaløy
    Timothy L. Lash
    Grethe I. G. Alnæs
    Ron H. van Schaik
    Emiel A. M. Janssen
    Steinar Hustad
    Ernst A. Lien
    Gunnar Mellgren
    Håvard Søiland
    Breast Cancer Research, 19
  • [4] Cost-effectiveness of adjuvant endocrine treatment with tamoxifen for male breast cancer
    Huang, Yaping
    Ke, Chengjie
    Cai, Jiaqin
    Wei, Xiaoxia
    Chen, Maohua
    Sun, Hong
    BREAST CANCER, 2024, 31 (05) : 917 - 925
  • [5] Serum concentrations of active tamoxifen metabolites predict long-term survival in adjuvantly treated breast cancer patients
    Helland, Thomas
    Henne, Nina
    Bifulco, Ersilia
    Naume, Bjorn
    Borgen, Elin
    Kristensen, Vessela N.
    Kvaloy, Jan T.
    Lash, Timothy L.
    Alns, Grethe I. G.
    van Schaik, Ron H.
    Janssen, Emiel A. M.
    Hustad, Steinar
    Lien, Ernst A.
    Mellgren, Gunnar
    Soiland, Havard
    BREAST CANCER RESEARCH, 2017, 19
  • [6] Improved Prediction of Endoxifen Metabolism by CYP2D6 Genotype in Breast Cancer Patients Treated with Tamoxifen
    Schroth, Werner
    Winter, Stefan
    Muerdter, Thomas
    Schaeffeler, Elke
    Eccles, Diana
    Eccles, Bryony
    Chowbay, Balram
    Khor, Chiea C.
    Tfayli, Arafat
    Zgheib, Nathalie K.
    Eichelbaum, Michel
    Schwab, Matthias
    Brauch, Hiltrud
    FRONTIERS IN PHARMACOLOGY, 2017, 8
  • [7] Influence of probenecid on endoxifen systemic exposure in breast cancer patients on adjuvant tamoxifen treatment
    Buck, Stefan A. J.
    Braal, C. Louwrens
    Hofman, Maaike M.
    Oomen-de Hoop, Esther
    de Bruijn, Peter
    Moghaddam-Helmantel, Inge M. Ghobadi
    Hussaarts, Koen G. A. M.
    Vastbinder, Mijntje B.
    Van Rossum-Schornagel, Quirine C.
    van Schaik, Ron H. N.
    Jager, Agnes
    Koolen, Stijn L. W.
    Mathijssen, Ron H. J.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
  • [8] Value of therapeutic drug monitoring of endoxifen in Egyptian premenopausal patients with breast cancer given tamoxifen adjuvant therapy: A pilot study
    EL Desoky, Ehab S.
    Taha, Amira F.
    Mousa, Heba Salah
    Ibrahim, Abeer
    Saleh, Medhat A.
    Abdelrady, Mohamed A.
    Hareedy, Mohammad Salem
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2023, 29 (07) : 1673 - 1686
  • [9] Cancer Care Coordinators to Improve Tamoxifen Persistence in Breast Cancer: How Heterogeneity in Baseline Prognosis Impacts on Cost-Effectiveness
    Nair, Nisha
    Kvizhinadze, Giorgi
    Blakely, Tony
    VALUE IN HEALTH, 2016, 19 (08) : 936 - 944
  • [10] Influence of green tea consumption on endoxifen steady-state concentration in breast cancer patients treated with tamoxifen
    Braal, C. Louwrens
    Hussaarts, Koen G. A. M.
    Seuren, Lieke
    Oomen-de Hoop, Esther
    de Bruijn, Peter
    Buck, Stefan A. J.
    Bos, Monique E. M. M.
    Thijs-Visser, Martine F.
    Zuetenhorst, Hanneke J. M.
    Mathijssen-van Stein, Danielle
    Vastbinder, Mijntje B.
    van Leeuwen, Roelof W. F.
    van Gelder, Teun
    Koolen, Stijn L. W.
    Jager, Agnes
    Mathijssen, Ron H. J.
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 184 (01) : 107 - 113
12345